M&A

Pfizer kicks newly acquired meds out of Arena as part of midstage cleaning
Fierce Biotech
Tue, 05/2/23 - 11:22 pm
Pfizer
Arena Pharmaceuticals
etrasimod
M&A
Sun's Concert hits bum note as FDA imposes partial hold 2 months after $576M buyout
Fierce Biotech
Tue, 05/2/23 - 10:19 am
Sun Pharma
Concerta Pharmaceuticals
M&A
FDA
AbbVie, Bristol Myers vied for Prometheus before Merck bought it
Crain's Chicago Business
Mon, 05/1/23 - 10:15 pm
Merck
Prometheus Biosciences
M&A
AbbVie
Bristol Myers Squibb
Astellas to acquire eye drug developer Iveric Bio for $5.9B
BioPharma Dive
Mon, 05/1/23 - 11:13 am
Astellas
M&A
Iveric Bio
eye health
'More in the hopper': European Big Pharmas hint M&A could ramp up
Fierce Biotech
Mon, 05/1/23 - 10:15 am
Europe
M&A
GSK
Novartis
Roche
Quest Expands in Cancer Testing With $300M Haystack Oncology Acquisition
MedCity News
Fri, 04/28/23 - 09:55 am
Quest Diagnostics
Haystack Oncology
diagnostics
M&A
liquid biopsy
Medtech
Sanofi, after $8B outlay, sees M&A strategy deliver 2 more duds
Fierce Biotech
Thu, 04/27/23 - 11:40 am
Sanofi
M&A
earnings
Ablynx
Principia Biopharma
3 Biotechs That Might Get Bought Out in 2023
Motley Fool
Wed, 04/26/23 - 05:41 pm
M&A
Madrigal Pharmaceuticals
Amylyx
Aurinia Pharmaceuticals
Big pharma’s biggest spenders revealed: 2022 edition
EP Vantage
Fri, 04/21/23 - 10:00 am
M&A
R&D
AbbVie
AstraZeneca
Bristol Myers Squibb
Eli Lilly
GSK
JNJ
Merck
Novartis
Pfizer
Roche
Sanofi
Big Pharmas finally strike with GSK, Merck acquisitions, signaling accelerating pace of M&A
Fierce Pharma
Tue, 04/18/23 - 10:10 pm
Big Pharma
M&A
Merck
Prometheus Biosciences
GSK
Bellus Health
GSK coughs up $2B for Bellus Health
Medical Marketing and Media
Tue, 04/18/23 - 10:24 am
GSK
Bellus Health
M&A
chronic cough
Camlipixant
Danaher backs away from Catalent as CDMO struggles with productivity problems: report
Fierce Pharma
Tue, 04/18/23 - 10:15 am
Catalent
Danaher
M&A
CDMOs
In Pfizer's $43B acquisition of Seagen, the biotech's patience paid off
Fierce Pharma
Mon, 04/17/23 - 10:49 pm
Pfizer
Seagen
M&A
Merck
Merck’s latest deal turns up the spotlight on immune system drugmakers
BioPharma Dive
Mon, 04/17/23 - 10:47 pm
Merck
M&A
Prometheus Biosciences
immunology
With skin in the game, Satsuma's partner offers buyout to get migraine spray to market
Fierce Biotech
Mon, 04/17/23 - 12:07 pm
Satsuma Pharmaceuticals
Japan
migraines
Shin Nippon Biomedical
M&A
Merck to buy inflammatory disease drugmaker Prometheus for $10.8B
BioPharma Dive
Sun, 04/16/23 - 11:31 pm
Merck
M&A
Prometheus Biosciences
IBD
Pfizer's fortunes overshadow first-quarter dealmaking
EP Vantage
Wed, 04/12/23 - 10:22 am
M&A
Pfizer
Seagen
Sanofi
Provention Bio
AstraZeneca
CinCor
Chiesi
Amryt
Ipsen
Albireo
Icahn pushes for spinoff of Illumina’s Grail division
BioPharma Dive
Tue, 04/11/23 - 07:16 pm
Illumina
Grail
Carl Icahn
M&A
spinoffs
Medtech
diagnostics
Sanofi's Provention buyout hit with FTC delay. Will Pfizer's Seagen deal go off as planned?
Fierce Pharma
Tue, 04/11/23 - 11:46 am
M&A
antitrust
FTC
Sanofi
Provention Bio
Pfizer
Seagen
Quince adopts 'poison pill' to fend off buyout bid as investor builds stake
Fierce Biotech
Thu, 04/6/23 - 11:32 am
Quince Therapeutics
M&A
Echo Lake Capital
poison pill

Pages